Abbott Laboratories (ABT) ROIC: History & Chart

Name: Abbott Laboratories (ABT) Return on Invested Capital (ROIC) — historical time series
Creator: TGMCharts

Compare

Abbott Laboratories(ABT)

Medical - Devices · Abbott Park, IL

$105.25+0.00 (+0.00%)

Delayed quote: Sep 9, 2026, 4:00 PM EDT

Compare

About Abbott Laboratories

Abbott Laboratories, along with its affiliated entities, is a global healthcare enterprise dedicated to the research, development, manufacturing, and worldwide distribution of a diverse portfolio of health solutions. The company operates through four primary divisions: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. In the Established Pharmaceutical Products segment, Abbott provides generic medications designed to treat a wide array of conditions, including pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorders, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine. This segment also supplies the anti-infective clarithromycin, influenza vaccines, and products aimed at regulating colon physiology. The Diagnostic Products division offers a comprehensive suite of diagnostic tools. These include laboratory systems for immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, as well as detect and quantify infectious agents. Additionally, this segment provides point-of-care systems, blood testing cartridges, rapid lateral flow testing products, and specialized molecular point-of-care tests for pathogens such as HIV, SARS-CoV-2, influenza A and B, RSV, and strep A. Its offerings also extend to cardiometabolic test systems, drug and alcohol screening solutions, remote patient monitoring, consumer self-test systems, and sophisticated informatics and automation solutions for laboratory use. The Nutritional Products segment is responsible for delivering nutritional formulations tailored for both pediatric and adult populations. Finally, the Medical Devices segment develops and commercializes rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular ailments. It also supplies diabetes care products and neuromodulation devices designed for the management of chronic pain and movement disorders. Founded in 1888, Abbott Laboratories maintains its corporate headquarters in North Chicago, Illinois.

Abbott Park, IL

115,000 employees

www.abbott.com

Healthcare / Medical - Devices

Sector: Healthcare
Industry: Medical - Devices
CEO: Robert Ford

View full financials

ABT Return on Invested Capital (ROIC) Metrics

RETURN ON INVESTED CAPITAL (ROIC)

6.07%

RETURN ON INVESTED CAPITAL (ROIC) AVG TTM

8.53%

RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y

8.96%

RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y

10.25%

RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y

7.77%

RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y

7.70%

RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y

8.31%

CURRENT VS TTM AVG

-28.87%

CURRENT VS 3Y AVG

-32.25%

CURRENT VS 5Y AVG

-40.79%

CURRENT VS 10Y AVG

-21.85%

CURRENT VS 15Y AVG

-21.15%

CURRENT VS 20Y AVG

-26.93%

SECTOR MEDIAN · HEALTHCARE

8.75%

median of 90 covered companies

CURRENT VS SECTOR MEDIAN

-30.61%

vs the sector median at left

NAME	MARKET CAP	RETURN ON INVESTED CAPITAL (ROIC)	TTM	3Y	5Y
Abbott Laboratories (ABT)	$182.12B	6.07%	8.53%	8.96%	10.25%
Gilead Sciences, Inc. (GILD)vs ›	$180.83B	-3.66%	11.34%	11.28%	10.29%
Novo Nordisk A/S (NVO)vs ›	$197.87B	30.21%	34.36%	43.28%	43.42%
Pfizer Inc. (PFE)vs ›	$158.33B	9.33%	9.06%	10.61%	10.43%
Amgen Inc. (AMGN)vs ›	$211.17B	14.22%	11.04%	11.80%	12.80%
Danaher Corporation (DHR)vs ›	$144.11B	5.03%	5.92%	6.55%	6.70%
Thermo Fisher Scientific Inc. (TMO)vs ›	$225.09B	7.44%	7.81%	8.16%	9.11%
Vertex Pharmaceuticals Incorporated (VRTX)vs ›	$132.26B	17.33%	8.72%	13.98%	17.04%
Bristol-Myers Squibb Company (BMY)vs ›	$131.57B	15.47%	14.35%	12.24%	10.38%
Intuitive Surgical, Inc. (ISRG)vs ›	$124.79B	15.11%	12.85%	12.25%	11.92%

NAME

MARKET CAP

RETURN ON INVESTED CAPITAL (ROIC)

TTM

Abbott Laboratories (ABT)

$182.12B

6.07%

8.53%

8.96%

10.25%

Gilead Sciences, Inc. (GILD)vs ›

$180.83B

-3.66%

11.34%

11.28%

10.29%

Novo Nordisk A/S (NVO)vs ›

$197.87B

30.21%

34.36%

43.28%

43.42%

Pfizer Inc. (PFE)vs ›

$158.33B

9.33%

9.06%

10.61%

10.43%

Amgen Inc. (AMGN)vs ›

$211.17B

14.22%

11.04%

11.80%

12.80%

Danaher Corporation (DHR)vs ›

$144.11B

5.03%

5.92%

6.55%

6.70%

Thermo Fisher Scientific Inc. (TMO)vs ›

$225.09B

7.44%

7.81%

8.16%

9.11%

Vertex Pharmaceuticals Incorporated (VRTX)vs ›

$132.26B

17.33%

8.72%

13.98%

17.04%

Bristol-Myers Squibb Company (BMY)vs ›

$131.57B

15.47%

14.35%

12.24%

10.38%

Intuitive Surgical, Inc. (ISRG)vs ›

$124.79B

15.11%

12.85%

12.25%

11.92%

Return on Invested Capital (ROIC) Formula & Definition

ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)

Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.

Return on Invested Capital (ROIC) FAQ

What is the return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The return on invested capital (ROIC) for ABT stock is 6.07%.

Is Abbott Laboratories's return on invested capital (ROIC) high or low?

The return on invested capital (ROIC) of 6.07% is 41% below its 5-year average of 10.25%, near the low end of its 5-year range (6.07%–14.17%).

What is the TTM average return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The TTM average return on invested capital (ROIC) for ABT stock is 8.53%.

What is the 3Y average return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The 3Y average return on invested capital (ROIC) for ABT stock is 8.96%.

What is the 5Y average return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The 5Y average return on invested capital (ROIC) for ABT stock is 10.25%.

What is the 10Y average return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The 10Y average return on invested capital (ROIC) for ABT stock is 7.77%.

What is the 15Y average return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The 15Y average return on invested capital (ROIC) for ABT stock is 7.70%.

What is the 20Y average return on invested capital (ROIC) for Abbott Laboratories (ABT)?

The 20Y average return on invested capital (ROIC) for ABT stock is 8.31%.

DATE	RETURN ON INVESTED CAPITAL (ROIC)
2026-06-30	6.07%
2026-03-31	6.56%
2025-12-31	8.43%
2025-09-30	10.98%
2025-06-30	10.62%
2025-03-31	10.42%
2024-12-31	9.97%
2024-09-30	9.33%
2024-06-30	9.27%
2024-03-31	9.17%
2023-12-31	9.13%
2023-09-30	8.37%
2023-06-30	8.12%
2023-03-31	9.27%
2022-12-31	11.36%
2022-09-30	13.11%
2022-06-30	14.17%
2022-03-31	13.85%
2021-12-31	12.56%
2021-09-30	12.97%
2021-06-30	11.49%
2021-03-31	9.73%
2020-12-31	7.79%
2020-09-30	6.39%
2020-06-30	5.99%
2020-03-31	6.95%
2019-12-31	7.02%
2019-09-30	6.31%
2019-06-30	5.93%
2019-03-31	5.64%
2018-12-31	5.35%
2018-09-30	2.96%
2018-06-30	2.97%
2018-03-31	2.37%
2017-12-31	1.59%
2017-09-30	2.65%
2017-06-30	2.11%
2017-03-31	2.66%
2016-12-31	4.90%
2016-09-30	6.62%
2016-06-30	7.25%
2016-03-31	6.92%
2015-12-31	6.67%
2015-09-30	6.57%
2015-06-30	5.79%
2015-03-31	5.47%
2014-12-31	5.17%
2014-09-30	4.88%
2014-06-30	5.46%
2014-03-31	5.65%
2013-12-31	6.38%
2013-09-30	10.97%
2013-06-30	10.87%
2013-03-31	10.79%
2012-12-31	6.42%
2012-09-30	6.02%
2012-06-30	6.04%
2012-03-31	8.90%
2011-12-31	10.86%
2011-09-30	10.44%
2011-06-30	10.84%
2011-03-31	9.60%
2010-12-31	10.15%
2010-09-30	10.54%
2010-06-30	11.94%
2010-03-31	12.01%
2009-12-31	11.18%
2009-09-30	11.71%
2009-06-30	11.66%
2009-03-31	11.74%
2008-12-31	13.72%
2008-09-30	12.83%
2008-06-30	10.78%
2008-03-31	11.10%
2007-12-31	11.08%
2007-09-30	6.31%
2007-06-30	6.21%
2007-03-31	5.03%
2006-12-31	5.20%
2006-09-30	10.46%
2006-06-30	10.02%
2006-03-31	13.55%
2005-12-31	13.39%
2005-09-30	13.67%
2005-06-30	14.80%
2005-03-31	12.96%
2004-12-31	12.53%
2004-09-30	13.08%
2004-06-30	12.24%
2004-03-31	9.96%
2003-12-31	10.70%
2003-09-30	10.35%
2003-06-30	10.96%

DATE

RETURN ON INVESTED CAPITAL (ROIC)

2026-06-30

6.07%

2026-03-31

6.56%

2025-12-31

8.43%

2025-09-30

10.98%

2025-06-30

10.62%

2025-03-31

10.42%

2024-12-31

9.97%

2024-09-30

9.33%

2024-06-30

9.27%

2024-03-31

9.17%

2023-12-31

9.13%

2023-09-30

8.37%

2023-06-30

8.12%

2023-03-31

9.27%

2022-12-31

11.36%

2022-09-30

13.11%

2022-06-30

14.17%

2022-03-31

13.85%

2021-12-31

12.56%

2021-09-30

12.97%

2021-06-30

11.49%

2021-03-31

9.73%

2020-12-31

7.79%

2020-09-30

6.39%

2020-06-30

5.99%

2020-03-31

6.95%

2019-12-31

7.02%

2019-09-30

6.31%

2019-06-30

5.93%

2019-03-31

5.64%

2018-12-31

5.35%

2018-09-30

2.96%

2018-06-30

2.97%

2018-03-31

2.37%

2017-12-31

1.59%

2017-09-30

2.65%

2017-06-30

2.11%

2017-03-31

2.66%

2016-12-31

4.90%

2016-09-30

6.62%

2016-06-30

7.25%

2016-03-31

6.92%

2015-12-31

6.67%

2015-09-30

6.57%

2015-06-30

5.79%

2015-03-31

5.47%

2014-12-31

5.17%

2014-09-30

4.88%

2014-06-30

5.46%

2014-03-31

5.65%

2013-12-31

6.38%

2013-09-30

10.97%

2013-06-30

10.87%

2013-03-31

10.79%

2012-12-31

6.42%

2012-09-30

6.02%

2012-06-30

6.04%

2012-03-31

8.90%

2011-12-31

10.86%

2011-09-30

10.44%

2011-06-30

10.84%

2011-03-31

9.60%

2010-12-31

10.15%

2010-09-30

10.54%

2010-06-30

11.94%

2010-03-31

12.01%

2009-12-31

11.18%

2009-09-30

11.71%

2009-06-30

11.66%

2009-03-31

11.74%

2008-12-31

13.72%

2008-09-30

12.83%

2008-06-30

10.78%

2008-03-31

11.10%

2007-12-31

11.08%

2007-09-30

6.31%

2007-06-30

6.21%

2007-03-31

5.03%

2006-12-31

5.20%

2006-09-30

10.46%

2006-06-30

10.02%

2006-03-31

13.55%

2005-12-31

13.39%

2005-09-30

13.67%

2005-06-30

14.80%

2005-03-31

12.96%

2004-12-31

12.53%

2004-09-30

13.08%

2004-06-30

12.24%

2004-03-31

9.96%

2003-12-31

10.70%

2003-09-30

10.35%

2003-06-30

10.96%

Return on Invested Capital (ROIC): 6.07%

ABT Return on Invested Capital (ROIC)

ABT Average Return on Invested Capital (ROIC) Chart

ABT Current vs Average Return on Invested Capital (ROIC) Chart

ABT Return on Invested Capital (ROIC) Metrics

ABT Competitors' Return on Invested Capital (ROIC)

Capital Efficiency

Return on Invested Capital (ROIC) Formula & Definition

Return on Invested Capital (ROIC) FAQ

ABT Return on Invested Capital (ROIC) History

Related Metrics